Affinity-purified monospecific antibodies against human fibrinogen and the platelet-specific proteins platelet factor 4 and beta thromboglobulin were used to localize these antigens in thin and ultra-thin frozen sections of mildly fixed, washed human blood platelets. By immunofluorescent double-labeling experiments the distribution of fibrinogen was compared to that of platelet factor 4 and beta thromboglobulin. All three antigens occurred in virtually all platelets and showed and identical, dotlike distribution. For immunoelectron microscopy we used protein A-colloidal gold on ultra-thin frozen sections to visualize the specific reaction indirectly. The staining for platelet factor 4, beta thromboglobulin, and fibrinogen localized exclusively over alpha-granules of washed platelets. Within the granules, platelet factor 4 was localized preferentially in the electron dense, alpha-granule nucleoid, whereas fibrinogen was more predominant in the electron-lucent granule periphery. Beta thromboglobulin localization did not show a preferential intragranular distribution.
INTRODUCTION
Blood platelets play a crucial role in the hemostatic process in that they arrest bleeding (1) and support blood vessel repair (2) and wound healing (3) . Platelets can be considered as anucleate secretory cells that discharge their secretory products upon specific stimuli, such as thrombin or collagen (4) . Unlike many other secretory cells, platelets do not undergo a recovery phase (4) .
The localization of the secretory substances within the platelet is important for understanding the platelet secretory process. Using morphologic criteria three possible secretory granule classes have been recognized: alpha granules, dense granules, and lysosomelike granules (5, 6) .
With biochemical cell fractionation techniques fibrinogen, platelet factor 4, and beta thromboglobulin were demonstrated in platelet fractions containing alpha granules (3, (7) (8) (9) . Morphologic evidence for these findings is provided by immunofluorescence studies (10) (11) (12) (13) . This technique, however, has a poor resolving power. Attempts to localize fibrinogen with the electron microscope failed (14) . Yet, more detailed morphological information on the intracellular distribution of these substances is necessary in order to know whether the localization is restricted to a-granules and also whether they are stored within the same granule or whether subpopulations of granules are present with different contents.
In this study we have used immunoelectron microscopy to investigate the subcellular distribution of fibrinogen, platelet factor 4, and beta thromboglobulin. We prefered to work with thin frozen sections (15, 16) because they combine optimal accessability of intracellular antigens to the immunoreagents with a good preservation of cellular ultrastructure. This technique has been successfully used for the demonstration of Factor VIII-related antigen (FVIII R:Ag)' in blood platelets by means of fluorescent antibodies (12, 17) .
METHODS
Methods were performed at room temperature, unless stated otherwise.
Chemicals. Theophyllin (1-3-dimethylxanthine), prostaglandin El, 3,3' Antibodies. Antifibrinogen from goat and rabbit was prepared as follows: fibrinogen was purified as described by Jakobsen and Kierulf (18) and Polson and Ruiz-Bravo (19) with minor modifications. The fibrinogen preparation showed as two closely spaced bands after sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) (20) without reduction and as three bands, the characteristic Aa, B#, and y chains (21) (22) (23) , with reduction.
Antibodies against purified fibrinogen were raised in rabbits by four weekly injections of 25 ug of fibrinogen and in goats by six weekly injections of 50 ytg fibrinogen, all in Freund's complete adjuvant. 1 wk after the last injection the animals were bled, and antifibrinogen IgG was affinity purified by adsorption to fibrinogen coupled to cyanogen bromide-activated agarose beads (CNBr-CL4B) according to the supplier's recipe (5 ml gel volume, 4 mg fibrinogen/ml agarose). The antibodies were eluted with 1 M KCNS and dialyzed for 16 h against phosphate-buffered saline (PBS; 10 mM phosphate, 150 mM NaCl; pH 7.4, 260 mosmol/kg). Monospecificity of these antifibrinogen preparations were first tested by immunodiffusion. Both, the goat and rabbit antibodies, gave one precipitation line against whole plasma, whereas no line against serum was observed. For a second specificity test we used a modified SDS-gel immunoperoxidase technique (24) : fibrinogen and washed platelets (see platelet preparation below) were boiled for 5 min in standard reduction mixture (20) and 50-ag samples were submitted to slab gel electrophoresis in a 7-15% gradient gel (SDS-PAGE) until the dye front had migrated for 5 cm into the separation gel. Subsequently the two lanes were cut out together to form a block of -50 X 25 X 4 cm, of which 40 ,um thick longitudinal cryosections (59 X 25 mm) were cut; after fixation in ethanol/acetic acid (85:14, vol/vol) and washing in PBS the gel sections were first incubated with specific antibodies. Immunoreactive bands in the gels were visualized through a second incubation with anti-first-step antibodies conjugated to horseradish peroxidase, resulting in a brown reaction product when mixed with diaminobenzidine and H202. On gels of both washed platelets and purified fibrinogen, the immunoreaction was restricted to three bands after incubation with goat or rabbit antifibrinogen.
The bands corresponded to the three fibrinogen chains after Coomassie Blue staining. This indicated that the antifibrinogens were specific for fibrinogen and that no other platelet proteins were detected.
Platelet factor 4 and beta thromboglobulin were isolated and characterized as described before (25, 26) . Purity of both antigens was >99% as determined by SDS-PAGE and radioimmunoassay (27, 28) . Antibodies to the two proteins were raised in rabbits and affinity purified by adsorption to insolubilized, pure antigens and eluted by glycine-HCI, pH 3. The specificity of antiplatelet factor 4 (31, 32) . For electron microscopy we only used the specific rabbit antibodies, which were marked indirectly by ferritin conjugated to goat anti-rabbit IgG (33) or by a protein A-colloidal gold (PAG) complex. PAG was prepared as described before (34) . Gold particles with an average size of 5 nm were prepared by reduction of gold chloride with white phosphorus and complexed with protein A according to Roth et al. (35) .
Platelet preparation. Platelets were freshly fixed (a) or after washing (b). washed platelet preparations blood (9 ml) was collected and mixed with 1 ml of a solution containing 20 mM theophyllin, 220 mM EDTA, and 1 mM prostaglandin El, prepared immediately before use. Blood and inhibitor solution were mixed by inverting the tube three times. 10 ml of the blood mixture was diluted with a mixture of 9 ml Krebs-Ringer buffer (4 mM KCI, 107 mM NaCl, 20 mM NaHCO3, 2 mM tion at 135 g for 10 min, pipetted off and transferred to a plastic tube in which the platelets were pelleted at 350 g for 10 min. Next the platelets were washed three times with 10 ml of the Krebs-Ringer buffer by repeated resuspension and centrifugation at 500 g for 10 min. Finally the pellet was resuspended in fixative and pelleted after [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] (16) .
The specificity of the staining was tested with blocking experiments. Anti-,-thromboglobulin y-globulin was serially diluted and studied for immunofluorescence of platelets. Absorption was performed with five times as much B-thromboglobulin as y-globulin, by incubation for 1 h at 37°C and overnight at 4°C. The sample was centrifuged (2 min 10.000 g, 4°C) and the supernatant was used for immunofluorescence studies. Similar studies were performed for antifibrinogen with fibrinogen and fibronectin purified according to Vuento and Vaheri (36) and for antiplatelet factor 4 with purified platelet factor 4, chondroitin-6-sulfate from shark cartilage, heparin, platelet factor 4, and chondroitin sulfate (1:1) and platelet factor 4 and heparin (1:1). Chondroitin sulfate or heparin were added to platelet factor 4 to solubilize it. Absorption of anti-fl-thromboglobulin with ,B-thromboglobulin, antiplatelet factor 4 with platelet factor 4 plus chondroitin sulfate or plus heparin and of antifibrinogen with fibrinogen abolished fluorescent staining of the platelets. Absorption of antifibrinogen with fibronectin had no effect.
RESULTS
Ultrastructure. The ultrastructure of human blood platelets has been established previously (37) (38) (39) and, in general, platelet morphology in the cryosections was very similar to that in plastic sections.
As judged from the presence of pseudopodia, the washed platelets were often activated. Dense bodies and glycogen particles were not discernible in immunocytochemically treated cryosections of platelets, even if they were fixed with up to 2% glutaraldehyde.
Immunofluorescence microscopy. Localization experiments with antifibrinogen, antiplatelet factor 4, and anti-,8-thromboglobulin with the indirect method in 200-nm cryosections of washed platelets revealed a similar dotlike labeling pattern for all three antibodies with no labeling of cytoplasm or cell membrane. To prove that the antigens were localized in the same platelet, or even the same granule, we investigated their distribution with a double-immunofluorescent labeling technique. Fig. 1 shows the labeling patterns for platelet factor 4 (B) and fibrinogen (C) and for beta thromboglobulin (E) and fibrinogen (F). For ible, indicating that platelet factor 4, fibrinogen, and beta thromboglobulin are stored not only in the same platelet but also in the same spots. Control experiments performed with sections incubated with fluoresceinconjugated goat antifibrinogen alone or mixed with the normal rabbit IgG fraction and subsequent labeling with rhodamine-conjugated goat anti-rabbit IgG antibodies showed no rhodamine fluorescence.
Immunoelectron microscopy. In washed platelets fibrinogen was demonstrated in granules with moderate electron density, the a-granules (Fig. 2 A and  B) , but not in the cytoplasmic matrix, mitochondria, or on the cell membrane.
Beta thromboglobulin (Figs. 3 and 4 ) and platelet factor 4 (Fig. 5) were localized in granules of the atype but not in the cytoplasm, mitochondria, or on the cell membrane. These results are in agreement with the dotlike labeling patterns that we found with our immunofluorescence experiments (Fig. 1 B, C The intragranular storage pattern of the three proteins differed conspicuously. Platelet factor 4 was localized mainly in the electron-dense nucleoid (Fig. 5) . Fibrinogen occupied the electron-lucent periphery of the granule content (Fig. 2 A, B) , whereas for beta thromboglobulin no preferential labeling of either nucleoid or periphery of the granules were observed. (Figs. 3 and 4 A, B) . DISCUSSION We investigated the distribution of fibrinogen, platelet factor 4, and beta thromboglobulin in lightly fixed platelets by immunolabeling of cryosections with a thickness varying from 200 nm for fluorescence microscopy, down to 100 nm for electron microscopy studies.
For immunofluorescence this procedure resulted in very good resolution, because superposition of different structures does not occur, as is the case when normal sections (>1 ,m) or whole cell preparations are used. This approach enabled us in an earlier study to prove that FVIII R:Ag-containing dots were localized inside the platelets and not at the cell surface (12) . In the present study we took advantage of this technique and the availability of double-labeling procedure for immunofluorescence to gain more information on the localization of fibrinogen, platelet factor 4, and beta thromboglobulin in platelets. All three proteins appeared to be distributed in an identical, intracellular, punctate pattern, which was similar to that described for FVIII R:Ag (12) .
Another advantage of the fact that the section thickness is below the diameter of the cells as well as most of its membrane-bound compartments, is that it gives optimal accessibility of intracellular immunoreactive sites, so that treatment to disrupt the membranes are no longer needed. Such treatments are harmful to the ultrastructure and may cause artifacts, such as a redistribution of antigens. This might have happened in other studies, where fibrinogen, in contrast to the present results, appeared in the cytoplasm but not in the a-granules (14) . Since we worked with properly fixed cells, the reactive dots observed in fluorescence experiments could easily be recognized as a-granules with the electron microscopic immunotechnique.
It is evident that all three substances, fibrinogen, platelet factor 4, and beta thromboglobulin, are localized in a-granules, and that virtually each granule contains all three proteins. Within the granule the antifibrinogen reaction occurred mainly in the periphery. Apparently this distribution is not caused by impaired antibody penetration into the electron-dense granule core (nucleoid), since antiplatelet factor 4 did react with the nucleoid, whereas in that case the granule periphery stained less. Therefore, we concluded that in the sections fibrinogen is predominantly localized in the electron-lucent periphery of the a-granules and that platelet factor 4 occurs mainly in the central part. Beta thromboglobulin exhibited an equal distribution over both parts.
The antibody raised against platelet factor 4 was made against a platelet factor 4-chondroitin sulfate complex. To exclude the possibility that contaminating antibodies against chondroitin sulfate might be present, absorption of the antiplatelet factor 4 was performed with a platelet factor 4-heparin complex as well as with a platelet factor 4-chondroitin sulfate complex. In both instances immunofluorescent staining was fully abolished, indicating that no antibodies against the proteoglycan carrier occurred in the affinity-purified antiplatelet factor 4 (40) .
Data from the literature indicate that the granule nucleoid contains a large amount of proteoglycan (41, 42) . The differential localization in the granule may therefore be explained by assuming that the larger fibrinogen molecule (mol wt 340,000) is excluded from the dense proteoglycan accumulation, whereas the much smaller beta thromboglobulin molecule (mol wt 36,000) may penetrate into this area.
Theoretically, this apparent heterogeneity of proteins, within an a-granule could be the result of preferential washout of the proteins. However, the complementary location of fibrinogen and platelet factor 4 in the presence of a homogenously distributed third factor, ,B-thromboglobulin, make the explanation of the phenomenon less likely.
We never noticed dense bodies in thin frozen sections, even if we raised the glutaraldehyde concentration to 2%. Their presence in similarly fixed and subsequently resin-embedded platelets (5) proved that they are lost as recognizable entities after cutting. Probably this is due to leakage of dense body constituents during immunocytochemical treatment, which makes them indistinguishable from a-granules, and yields the unlabeled granules that we occasionally find.
FICURE 5 Ultrathin cryosections of freshly fixed platelets, immunostained with PAG for platelet factor 4 . Immunoreactivity occurs in a-granules. Sometimes label is evenly distributed over the entire granules (asterisk) but often the dark nucleoids are stained preferentially (arrows In experiments where platelets were stimulated to secrete, platelet factor 4 and beta thromboglobulin were released in parallel (9, 43, 44) , which points to a common storage site. However, Zucker et al. (9) found different release patterns for fibrinogen and beta thromboglobulin, suggesting a possibly different storage site for beta thromboglobulin and platelet factor 4 compared with fibrinogen. Also FVIII R:Ag, a protein also reported to be localized in ca-granules (12, 17) , showed release kinetics similar to fibrinogen, but different from beta thromboglobulin. The common localization of fibrinogen, as reported here, has implications for the understanding of the platelet secretion reaction. Release differences between these proteins (9, 44) might therefore result from differential storing of secretory proteins in the open canalicular system.
The occurrence of fibrinogen, platelet factor 4, and beta thromboglobulin in the same granules is in agreement with biochemical experiments, in which cell fractionation was used as a technique for the localization of proteins in platelets (1, 4, 8, 10, 13) . Fibrinogen (10, 13), platelet factor 4 (8) , and beta thromboglobulin (7) were found in subcellular fractions enriched for a-granules and not in the membrane fraction or soluble fraction. Our results complement the known biochemical data in that they show that all platelets and virtually all a-granules contain the same substances and that it is unlikely that a-granule subpopulations exist. This, in turn means that the reported nonparallel release cannot be attributed to graded secretion steps and necessarily must be a result of interactions that take place after the secretion process has induced the granules to be exocytosed.
It is unknown how the secreted a-granule substances behave between leaving the secretion granule and before appearing in the platelet-suspending medium. Ginsberg et al. (46) have shown that large vacuoles occurred in thrombin-treated platelets, which contained platelet factor 4 before it was secreted from the cell. Specific retention of some proteins in these vacuoles might explain nonparallel release.
